NCT04612283View on ClinicalTrials.gov

NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2020

Primary Completion Date

January 15, 2022

Study Completion Date

January 25, 2022

Conditions
Arthritis Osteoarthritis
Interventions
OTHER

NGA-01 gel

NGA-01 is a gel formulation with mostly herbal active ingredients

OTHER

Placebo

A Placebo with no active ingredients

Trial Locations (1)

411033

Moraya Multispeciality Hospital, Pune

Sponsors
All Listed Sponsors
collaborator

Galaxa Pharma

UNKNOWN

collaborator

Mittal Global Clinical Trial Services

UNKNOWN

lead

Nutrin GmbH

NETWORK

NCT04612283 - NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain | Biotech Hunter | Biotech Hunter